INNATE PHARMA: ifrs:CurrentAssets
| Value | {"amount": 148012000.0} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/c1928223-e422-4c00-bd71-64e76c50a6ff
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2023-12-31Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
8cc6e40d8d62bf3f280603498c300fb9…Cite as: FACTANKER, https://factanker.com/fact/c1928223-e422-4c00-bd71-64e76c50a6ff
History
- supersedes {"amount": 148013000.0} (evidence esef:9695002Y8420ZB8HJE29:2024-12-31)